Karyopharm Therapeutics Inc.
KPTIBiotechnology
$0.88+5.73%As of Oct 29vs prior close
- Market cap
- $20M
- P/E (TTM)
- –
- From 52W high
- −91.75%
- EPS (LTM)
- -$14.40
- Revenue (LTM)
- $146.6M
- Net margin
- -153.28%
- Dividend yield
- 0.00%
Nomior Score
28
Steady ProfileSpeculativeBottom 14% of the scored universe
Growth48
Quality42
Value—
Momentum19
Resilience31
Growth
+114.18%revenue a year over 9 fiscal years
YE16 $154KLTM $146.6M
Connections
Revenue to profitQ2 YE26
The operating loss was 67% of revenue, wider by 3 pts on a year.
Who owns it
2funds